HBM Healthcare Investments invests USD 4.5 million in Lycia Therapeutics IPO
LYCA•HBM Healthcare Investments invested USD 4.5 million in Lycia Therapeutics’ IPO, bringing its total investment to USD 13.5 million and its post-IPO stake to approximately 2.2%. Lycia raised USD 317.5 million by issuing 17,640,000 shares at USD 18 each.
1. Investment and IPO
HBM Healthcare Investments invested USD 4.5 million in Lycia Therapeutics’ IPO, bringing its total investment to USD 13.5 million. Its initial USD 9 million investment came through Lycia’s Series D financing in June 2026, and its post-IPO stake is approximately 2.2%. Lycia raised gross proceeds of USD 317.5 million by issuing 17,640,000 new shares at USD 18 each.
2. Trading debut
Lycia shares began trading on the Nasdaq Global Select Market on October 23, 2026. The stake was valued at USD 36.8 million at the first-day closing price of USD 30, up 66.7% from the IPO price.
